Grant of Options

RNS Number : 0167E
Judges Scientific PLC
03 November 2020
 

Press Release


 

 

Judges Scientific plc

 

("Judges Scientific")

 

Grant of Options

 

Judges Scientific announces that it has issued options over 3,000 new ordinary shares of 5 pence each in the Company ("Ordinary Shares") at an exercise price of £52.00. As disclosed in the 2019 Annual Report and Accounts, 1,000 options were awarded by the Remuneration Committee to each of the Executive Directors, with performance conditions of 6% compound growth in Earnings per Share, to be granted at the earliest opportunity following the issue of the 2019 financial statements.

 

Director

Number of options

Option Scheme

Vesting date

Expiry date

David Cicurel

1 ,000

Unapproved

03/11/2023

02 /11/2030

Brad Ormsby

576

Approved

03/11/2023

02 /11/2030

Brad Ormsby

4 24

Unapproved

03/11/2023

02 /11/2030

Mark Lavelle

1,000

Unapproved

03/11/2023

02 /11/2030

 

  Ends -  

 

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

   Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

 

 

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

 

Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

 

Alma (Financial Public Relations)

Rebecca Sanders-Hewett

Sam Modlin

 

 

Tel: +44 (0) 20 3100 2222 

 

 

 

 

Tel: +44 (0) 20 3865 9886

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

David Cicurel

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Grant of Options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

5,200.0p

1,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

e)

 

Date of the transaction

 

 

02/11/2020

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (XLON)

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Bradley Ormsby

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group Finance Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Grant of Options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

5,200.0p

1,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

e)

 

Date of the transaction

 

 

02/11/2020

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (XLON)

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Mark Lavelle

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Operating Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Grant of Options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

5,200.0p

1,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

e)

 

Date of the transaction

 

 

02/11/2020

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (XLON)

 

 

 

 

 

Notes to editors:  

 

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies  in the scientific instrument sector .  The Group now consists of 19 businesses acquired since it was re-admitted to AIM in 2005.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments.  The Group companies hold five Queen's Awards for innovation and export.

 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.  Shareholder returns are created through the repayment of debt, organic growth and dividends.

 

For further information, please visit  www.judges.uk.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZMGMGZVGGZZ
UK 100

Latest directors dealings